Woven stent with improved flexibility

By using multiple interwoven filaments and polymer covers in the medical stent, the problem of both flexibility and strength in the body cavity is solved, and effective lumen patency and stable deployment in the case of esophageal stenosis are achieved.

CN119072284APending Publication Date: 2024-12-03BOSTON SCIENTIFIC SCIMED INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380017648.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-01-19
Filing Date
2023-01-18
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing medical stent is difficult to balance the flexibility and strength in the body cavity, making it difficult to achieve effective lumen patency and stable deployment in medical conditions such as esophageal stenosis.

Method used

A braided bracket consisting of multiple interwoven filaments is designed to increase the flexibility of the bracket by cutting on the filaments, while ensuring structural stability and migration resistance characteristics using polymer covers and fixing elements. .

Benefits of technology

It is achieved to provide sufficient flexibility in the body cavity to accommodate complex anatomical structures while maintaining the necessary strength and migration resistance to ensure stable deployment and effective use of the stent.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119072284A_ABST
    Figure CN119072284A_ABST
Patent Text Reader

Abstract

A stent includes an elongate tubular member expandable from a radially collapsed configuration to a radially expanded configuration, the elongate tubular member including a first plurality of filaments extending in a first helical direction and a second plurality of filaments extending in a second helical direction, the first plurality of filaments extending in the first helical direction and the second plurality of filaments extending in the second helical direction overlap to form a plurality of cells arranged in rows extending circumferentially around the elongate tubular member. At least some of the cells within the one or more rows are adapted to provide increased flexibility to the stent.
Need to check novelty before this filing date? Find Prior Art

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application claims the benefit of U.S. Provisional Patent Application Serial No. 63 / 300,810, filed on January 19, 2022, which is incorporated herein by reference. Technical Field

[0002] The present invention relates to medical devices and methods for making and using medical devices. More particularly, the present invention relates to stents for implantation in body cavities and associated methods. Background Art

[0003] Implantable medical devices (e.g., expandable stents) can be designed to treat various medical conditions in the body. For example, some expandable stents can be designed to expand radially and support a body cavity and / or provide a fluid pathway for digestive substances, blood flow, or other fluids to flow through the fluid pathway after a medical procedure. Some medical devices can include radial or self-expanding stents that can be implanted percutaneously via various medical device delivery systems. These stents can be implanted in various body cavities, such as coronary or peripheral arteries, esophagus, gastrointestinal tract (including intestines, stomach, and colon), tracheobronchial, urinary tract, biliary tract, vascular system, etc. In some cases, it may be desirable to design the stent to include sufficient flexibility while maintaining sufficient radial force to open the body cavity at the treatment site.

[0004] Therefore, in some cases, it may be desirable to design a stent with increased flexibility.Examples of medical devices including increased flexibility are disclosed herein. Summary of the invention

[0005] The present invention provides designs, materials, manufacturing methods and use alternatives for medical devices. As an example, a stent includes an elongated tubular member expandable from a radially collapsed configuration to a radially expanded configuration, the elongated tubular member including a first plurality of filaments extending in a first helical direction and a second plurality of filaments extending in a second helical direction, the first plurality of filaments extending in the first helical direction and the second plurality of filaments extending in the second helical direction overlap to form a plurality of cells arranged in a plurality of rows extending circumferentially around the elongated tubular member. At least some of the cells within one or more rows are adapted to provide increased flexibility to the stent.

[0006] Alternatively or additionally, at least some of the first plurality of filaments and at least some of the second plurality of filaments within one or more of the plurality of rows may be cut to break at least some of the cells, thereby increasing the flexibility of the stent.

[0007] Alternatively or additionally, at least some of the plurality of cells may have a generally rhombus shape having four sides formed by a pair of filaments of the first plurality of filaments extending in a first helical direction and a pair of filaments of the second plurality of filaments extending in a second helical direction.

[0008] Alternatively or additionally, the fractured cells may include cells from which at least one of the four sides of the generally diamond shape has been removed.

[0009] Alternatively or additionally, the stent may also include a polymer covering extending along the elongated tubular member.

[0010] Alternatively or additionally, one or more rows of cells may include at least one complete cell and a plurality of broken cells.

[0011] Alternatively or additionally, one or more rows of cells may include only break cells, thereby dividing the elongated tubular member into two or more distinct segments.

[0012] Alternatively or additionally, a first segment of the two or more different segments may have a first end having a plurality of small grids within a first last row, a second segment of the two or more different segments may have a second end having a plurality of small grids within a second last row, and the second segment may be rotated relative to the first segment so that the plurality of small grids within the first last row are nested between the plurality of small grids within the second last row.

[0013] Alternatively or additionally, a first segment of the two or more different segments may have a first weave pattern and a second segment of the two or more different segments may have a second weave pattern that is different from the first weave pattern.

[0014] Alternatively or additionally, the first braid pattern may differ from the second braid pattern in one or more of the number of filaments, braid angles, and filament diameters.

[0015] Alternatively or additionally, two or more different segments may be bonded together via a securing element woven between adjacent segments.

[0016] Alternatively or additionally, the fixation element may comprise a filament.

[0017] Alternatively or additionally, two or more different segments may be formed by breaking all cells within a row of cells.

[0018] As another example, a braided stent includes an elongated tubular member that can be expanded from a radially collapsed configuration to a radially expanded configuration. The elongated tubular member includes a first section, the first section includes a first plurality of filaments extending in a spiral direction from left to right, and a second plurality of filaments extending in a spiral direction from right to left, the first plurality of filaments and the second plurality of filaments together forming a first plurality of small grids arranged in multiple rows extending circumferentially around the first section. The elongated tubular member includes a second section, the second section includes a third plurality of filaments extending in a spiral direction from left to right, and a fourth plurality of filaments extending in a spiral direction from right to left, the third plurality of filaments and the fourth plurality of filaments together forming a second plurality of small grids arranged in multiple rows extending circumferentially around the second section. The first section and the second section are coupled together in a manner that provides increased flexibility to the braided stent.

[0019] Alternatively or additionally, the first segment and the second segment may be coupled together by having one or more of the third plurality of filaments serve as extensions of one or more of the first plurality of filaments and / or by having one or more of the fourth plurality of filaments serve as extensions of one or more of the second plurality of filaments.

[0020] Alternatively or additionally, the first segment and the second segment may be coupled together by a continuous polymer layer extending over at least a portion of the first segment and at least a portion of the second segment.

[0021] Alternatively or additionally, the first segment may have a first end having a plurality of cells within the first last row, and the second segment may have a second end having a plurality of cells within the second last row. The first segment and the second segment may be coupled together via a fixing element woven between the plurality of cells within the first last row and the plurality of cells within the second last row.

[0022] Alternatively or additionally, the braided stent may also include a third segment, the third segment including a fifth plurality of filaments extending in a spiral direction from left to right, and a sixth plurality of filaments extending in a spiral direction from right to left, the first plurality of filaments and the second plurality of filaments together forming a first plurality of small grids arranged in multiple rows extending circumferentially around the first segment, wherein the first segment and the second segment may be coupled together in a manner that provides increased flexibility to the braided stent.

[0023] In another example, a braided stent includes an elongated tubular member expandable from a radially collapsed configuration to a radially expanded configuration, the elongated tubular member having a plurality of cells arranged in a plurality of rows extending circumferentially around the elongated tubular member. At least some of the plurality of cells are adapted to increase the flexibility of the stent.

[0024] Alternatively or additionally, the elongated tubular member may include a first plurality of filaments extending in a first helical direction and a second plurality of filaments extending in a second helical direction, the first plurality of filaments extending in the first helical direction and the second plurality of filaments extending in the second helical direction overlapping to form a plurality of small grids arranged in a plurality of rows extending circumferentially around the elongated tubular member, wherein at least some of the first plurality of filaments and at least some of the second plurality of filaments in one or more of the plurality of rows are cut off to break at least some of the small grids, thereby increasing the flexibility of the stent.

[0025] The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present invention. The following figures and detailed description more particularly exemplify these embodiments. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] The present invention may be more fully understood by considering the following detailed description of various embodiments of the invention taken in conjunction with the accompanying drawings, in which:

[0027] Figure 1 is a side view of an illustrative bracket;

[0028] Figure 1A yes Figure 1 an enlarged view of a portion of an illustrative stent;

[0029] Figure 2 yes Figure 1 an enlarged view of a portion of an illustrative stent;

[0030] Figure 3 is a side view of an illustrative bracket;

[0031] Figure 4 yes Figure 3 an enlarged view of a portion of an illustrative stent;

[0032] Figure 5 is a side view of an illustrative bracket;

[0033] Figure 6 yes Figure 5 an enlarged view of a portion of an illustrative stent;

[0034] Figure 7 is a side view of an illustrative bracket;

[0035] Figure 8 is a side view of an illustrative bracket;

[0036] Fig. 9 is a side view of an illustrative bracket;

[0037] Fig.10 is a side view of an illustrative bracket;

[0038] Fig.11 is a side view of an illustrative bracket;

[0039] Fig.12 is a side view of an illustrative bracket;

[0040] Fig. 12A yes Fig.12 an enlarged view of a portion of an illustrative stent;

[0041] Fig.13 is a side view of a portion of an illustrative bracket;

[0042] Fig.13A It is along Fig.13 A schematic cross-sectional view taken along line 13A-13A of ;

[0043] Fig.14 is a side view of an illustrative bracket;

[0044] Fig.14A It is along Fig.14 A schematic cross-sectional view taken along line 14A-14A of ;

[0045] Fig. 14B It is along Fig.14 A schematic cross-sectional view taken along line 14B-14B of FIG.

[0046] Fig.15 is a side view of an illustrative bracket;

[0047] Fig.15A yes Fig.15 an enlarged view of a portion of;

[0048] Fig.16 is a side view of an illustrative bracket;

[0049] Fig.17 is a side view of an illustrative bracket;

[0050] Fig.18 is a side view of an illustrative bracket;

[0051] Fig.19 is a side view of an illustrative bracket;

[0052] Fig.19A yes Fig.19 an enlarged view of a portion of an illustrative stent;

[0053] Fig. 20 is a side view of an illustrative bracket; and

[0054] Fig. 20A yes Fig. 20 An enlarged view of a portion of.

[0055] Although the present invention is suitable for various modifications and alternative forms, its specific details have been shown in the drawings by way of example and will be described in more detail. However, it should be understood that it is not intended to limit the present invention to the specific embodiments described. On the contrary, it is intended to cover all modifications, equivalents and substitutes that fall within the spirit and scope of the present invention. DETAILED DESCRIPTION

[0056] For the following defined terms, these definitions shall apply unless a different definition is given in the claims or elsewhere in this specification.

[0057] All numerical values ​​are assumed herein to be modified by the term "about", whether or not expressly indicated. The term "about" generally refers to a range of numbers that one skilled in the art considers to be equivalent to the referenced value (i.e., having the same function or result). In many cases, the term "about" may include numbers that are rounded to the nearest significant figure.

[0058] The recitation of numerical ranges by endpoints includes all numbers within that range (eg, 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).

[0059] As used in this specification and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term "or" is generally employed in its sense including "and / or" unless the content clearly dictates otherwise.

[0060] The following detailed description should be read with reference to the drawings, in which similar elements in different drawings have the same reference numerals. The drawings, which are not necessarily drawn to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.

[0061] In some cases, it may be desirable to provide an intraluminal implant or stent that can achieve lumen patency in patients with esophageal stenosis or other medical conditions. Such stents can be used for patients experiencing dysphagia, which is sometimes caused by esophageal cancer. Esophageal stents can allow patients to maintain nutrition via oral intake during cancer treatment or palliative care. Some stents have a woven or knitted form to provide good radial strength with minimal perspective shortening, which may be desirable in esophageal and tracheobronchial applications and in some bariatric surgery applications. Although the embodiments disclosed herein are discussed with reference to esophageal stents, it is conceivable that the stents described herein can be used and have appropriate sizes for use in other locations, such as, but not limited to body tissues, body organs, vascular cavities, non-vascular cavities and combinations thereof, for example, but not limited to, in coronary arteries or peripheral vessels, trachea, bronchi, colon, small intestine, bile duct, urethra, prostate, brain, stomach, etc.

[0062] Figure 1 1 is a side view of an illustrative intraluminal implant 10, such as, but not limited to, a stent. In some cases, the stent 10 can take the form of an elongated tubular member. Although the stent 10 is described and shown as being generally tubular, it is contemplated that the stent 10 can take any desired cross-sectional shape. The stent 10 can have a first or proximal end 12, a second or distal end 14, and an intermediate region 16 disposed between the first end 12 and the second end 14. The stent 10 can include a lumen 18 extending from a first opening adjacent to the first end 12 to a second opening adjacent to the second end 14 to allow food, fluids, etc. to pass therethrough.

[0063] The stent 10 can be expanded from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, the stent 10 can be deployed to a configuration between the collapsed configuration and the expanded configuration, that is, the stent 10 can be deployed with a deployment diameter that is larger than the diameter of the stent 10 or a specific portion thereof in its collapsed configuration, but still smaller than the diameter of the stent 10 or a specific portion thereof in its fully expanded configuration. In some cases, the anatomical structure in which the stent 10 is deployed may affect its deployment configuration. For example, if the diameter of the anatomical structure in which the stent 10 is to be deployed is smaller than the diameter of the stent 10 or a specific portion thereof when fully expanded, the deployment diameter of the stent 10 can be between its collapsed configuration diameter and its fully expanded configuration diameter.

[0064] The stent 10 can be formed of a plurality of interwoven filaments. For example, the stent 10 can have a braided structure made of a plurality of filaments, the plurality of filaments including a first plurality of filaments each extending in a first helical direction and a second plurality of filaments each extending in a second helical direction. It is contemplated that the filaments of the stent 10 can be made of a variety of different materials, such as but not limited to metals, metal alloys, shape memory alloys, and / or polymers, as desired, so that the stent 10 can expand to an appropriate shape when accurately positioned within the anatomical structure. In some cases, the material can be selected so that the stent 10 can also be relatively easily removed. For example, the stent 10 can be made of alloys, such as but not limited to nitinol and Formed. Depending on the materials selected for constructing the stent 10, the stent 10 may be self-expanding, i.e., configured to automatically expand radially when unconstrained. In some cases, the stent 10 may not be self-expanding and therefore may not be able to return to its fully expanded configuration without the assistance of an expansion device, such as, but not limited to, an inflatable balloon disposed within the cavity 18. As used herein, the term "self-expanding" refers to the tendency of the stent 10 to return to a preprogrammed diameter when not constrained by an external biasing force, such as, for example, a delivery catheter or sheath. Although not shown, the stent 10 may include a one-way valve, such as an elastomeric slit valve or a duckbill valve, positioned within the cavity 18 to prevent, for example, reflux of gastrointestinal fluids.

[0065] In some cases, in the radial expansion configuration, the stent 10 may include a first end region 20 adjacent to the first end 12 and a second end region 22 adjacent to the second end 14. In some cases, as shown, the first end region 20 and the second end region 22 may include a retention feature or an anti-migration flared region with an expanded diameter relative to the middle region 16. The anti-migration flared region that can be positioned adjacent to the first end 12 and / or the second end 14 may be configured to engage the inner portion of the wall of the esophagus or other body cavity. In some cases, the diameter of the retention feature or flared region may be greater than the middle region 16 of the stent 10 to prevent the stent 10 from migrating once placed in the esophagus or other body cavity. In some cases, the transition from the cross-sectional area of ​​the middle region 16 to the retention feature or flared region may be gradual, inclined, or occur in a sudden stepped manner as required.

[0066] In some cases, the first anti-migration flared region may have a first outer diameter, and the second anti-migration flared region may have a second outer diameter. In some cases, the first outer diameter and the second outer diameter may be approximately the same, while in other cases, the first outer diameter and the second outer diameter may be different. In some cases, the stent 10 may include only one anti-migration flared region or may not include any anti-migration flared region. For example, the first end region 20 may include an anti-migration flare, while the second end region 22 may have an outer diameter similar to that of the middle region 16. It is also conceivable that the second end region 22 may include an anti-migration flare, while the first end region 20 may have an outer diameter similar to that of the middle region 16. In some embodiments, the stent 10 may have a uniform outer diameter from the first end 12 to the second end 14. In some embodiments, the outer diameter of the middle region 16 may be in the range of 15 to 25 mm in the fully expanded form. The outer diameter of the anti-migration flare may be in the range of 20 to 30 mm in the fully expanded form. It is conceivable that the outer diameter of the stent 10 may vary to suit the desired application.

[0067] In some cases, the stent 10 includes a first plurality of filaments extending in a first spiral direction and a second plurality of filaments extending in a second spiral direction. The stent 10 includes, for example, each filament 24a, 24b and 24c extending in the first spiral direction. The stent 10 includes an additional filament (not mentioned) extending in the first spiral direction. The first spiral direction can be considered to extend from left to right in a clockwise direction, or from the proximal side to the distal side. The stent 10 includes, for example, each filament 26a, 26b and 26c extending in the second spiral direction. The stent 10 includes an additional filament (not mentioned) extending in the second spiral direction. The second spiral direction can be considered to extend from right to left in a clockwise direction, or from the distal side to the proximal side.

[0068] refer to Figure 1A, it can be seen that each filament is braided, that is, each braid extends above and below each other. For example, each filament 24a extends below each filament 26a, extends above each filament 26b, extends below each filament 26c, etc. For each of the filaments forming the support 10, there is a similar relationship. It should be understood that the small grid 28a is formed by the intersection of each filament 24a, 24b, 26a and 26b. The small grid 28b is formed by the intersection of each filament 24b, 24c, 26a and 26b. The small grid 28c is formed by the intersection of each filament 24b, 24c, 26b and 26c. Each of the small grids 28a, 28b and 28c can be regarded as a rhombus, with four sides of approximately equal length. In some cases, according to the relative angles extending respectively from the first spiral direction and the second spiral direction, at least some of the small grids can have, for example, two slightly shorter sides and two slightly longer sides. Cells 28 a and 28 c may be considered to be in a single row extending circumferentially around stent 10 , while cells 28 b may be considered to be in an adjacent row extending circumferentially around stent 10 .

[0069] The support 10 may include any number of filaments extending in the first spiral direction and any number of filaments extending in the second spiral direction. In some cases, the support 10 may have an equal number of filaments extending in the first spiral direction and in the second spiral direction. In some cases, the support 10 may have a relatively large number of filaments extending in the first spiral direction and a relatively small number of filaments extending in the second spiral direction. For example, the support 10 may have a relatively small number of filaments extending in the first spiral direction and a relatively large number of filaments extending in the second spiral direction. For example, the support 10 may also include one or more filaments extending in the longitudinal direction. In some cases, the support 10 may have six, seven, eight, nine, ten, eleven, twelve or more filaments extending in the first spiral direction, and may have six, seven, eight, nine, ten, eleven or twelve or more filaments extending in the second spiral direction.

[0070] It should be understood that in many cases, the performance requirements for a stent, such as stent 10, may conflict. For example, strength, including axial strength and radial strength and flexibility are common conflicts in designing medical devices, such as stents. Constructing a stent that can be assembled into an anatomical structure that may be tortuous may conflict with the desire to provide the desired strength. Constructing a stent that will remain in place and will not migrate may conflict with the desire to be able to move or even remove the stent. These are just examples. In some cases, stent 10 may include one or more features that can increase the flexibility of stent 10 while maintaining the required axial strength and / or radial strength.

[0071] In some cases, the flexibility of the stent 10 or at least a portion thereof can be increased by cutting or otherwise removing some of the segments of each filament. For example, the stent 10 includes a first gap 30 and a second gap 32. In some cases, the first gap 30 and the second gap 32 can be different gaps. As shown, a single complete small grid 34 is provided between the first gap 30 and the second gap 32. A similar complete small grid (not visible) may exist on the back of the stent 10 provided between the first gap 30 and the second gap 32. In some cases, the first gap 30 and the second gap 32 can actually be shared with each other on the back of the stent 10 without a complete small grid in the middle. Although the first gap 30 and the second gap 32 are aligned with a single circumferential row of the stent 10, in some cases, the first gap 30 and / or the second gap 32 can be multiple rows wide. As will be discussed, in some cases, the stent 10 can include multiple gaps extending at least partially around the stent 10 circumferentially, and the gaps can be located at multiple axial positions (multiple spaced rows) separated longitudinally along the stent 10.

[0072] The first void 30 and the second void 32 may extend circumferentially around the stent 10 at a first axial position of the stent 10, or if desired, each of the first void 30 and the second void 32 may extend circumferentially around the stent 10 at first and second axially spaced positions of the stent 10. The first void 30 and / or the second void 32 may extend circumferentially around any desired arc length of the circumference of the stent 10. For example, each of the first void 30 and / or the second void 32 may extend 30 degrees or more, 40 degrees or more, 45 degrees or more, 60 degrees or more, 75 degrees or more, 85 degrees or more, 90 degrees or more, 120 degrees or more, 150 degrees or more, or 180 degrees or more around the circumference of the stent 10.

[0073] Figure 2An enlarged view of a portion of support 10 is provided. It can be seen that a single complete small grid 34 is formed by the intersection of filaments 36a and 36b extending in the first spiral direction and filaments 38a and 38b extending in the second spiral direction. The first gap 30 is formed by cutting or otherwise removing a portion of filaments 40a, 40b and 40c extending in the first spiral direction and cutting or otherwise removing a portion of filaments 42a, 42b and 42c extending in the second spiral direction. According to the overall size of how many filaments and the first gap 30 included in support 10, the extra filaments extending in the first spiral direction and / or in the second spiral direction can also be excised or otherwise removed its portion. The second gap 32 is formed by cutting or otherwise removing a portion of filaments 44a, 44b and 44c extending in the first spiral direction and cutting or otherwise removing a portion of filaments 46a, 46b and 46c extending in the second spiral direction. A cell that is no longer intact may be considered a broken cell, ie, a cell that was previously defined by removed portions of the filaments of the braided tubular member, thereby merging multiple cells together without intermediate filaments therebetween.

[0074] The broken cells can be formed by cutting the parts of each filament, and thus a plurality of cells are merged together without the intermediate filaments therebetween. This can include laser cutting each filament. Although not clearly shown, in some cases, at least some of the cut filament ends can be welded together to fix the remaining cells. In some cases, this can include sawing or even grinding each filament. In some cases, regardless of the procedure for removing the parts in each filament, each filament can have a cut end that extends slightly beyond the intersecting filaments. As an example, looking at the missing section from a single filament 40b, it can be seen that the cut ends of each filament 40b extend slightly beyond each filament 42a and 42b.

[0075] The fractured small grid can be formed at any stage of manufacturing the stent 10. In some cases, before forming any of the fractured small grids, the stent 10 is braided and annealed to set the memory shape of the stent 10. By annealing the stent 10 before cutting any part of any of the individual filaments, the cut end of any cut filament will tend to "remember" its shape and thus remain in place. In some cases, the inner and / or outer surfaces of the stent 10 can be completely, substantially or partially covered with a polymer covering or coating 48 (shown via a dotted pattern). The covering or coating 48 can span the complete small grid, as well as the fractured small grid. For example, the covering or coating 48 can help reduce food impaction and / or the ingrowth of a tumor or tissue. In some cases, after the voids 30 and 32 have been formed, the covering or coating 48 can be dip-coated onto the stent 10. After the voids 30 and 32 have been formed, the covering or coating 48 can be sprayed onto the stent 10. In some cases, the covering or coating 48 can be formed by any desired polymer material. The covering or coating 48 can also help the stent 10 maintain its shape even after the filaments have been cut or otherwise removed. The covering or coating 48 can also help prevent tissue ingrowth into the first voids 30 and / or the second voids 32.

[0076] Figure 3 is a side view of an illustrative intraluminal implant 50, such as, but not limited to, a stent. Stent 50 can take the form of an elongated tubular member, however, stent 50 can also take any desired cross-sectional shape. For example, stent 50 can have a braided structure made of a plurality of filaments, the plurality of filaments including a first plurality of filaments each extending in a first helical direction and a second plurality of filaments each extending in a second helical direction.

[0077] The stent 50 may have a first or proximal end 12, a second or distal end 14, and an intermediate region 16 disposed between the first and second ends 12, 14. The stent 50 may include a lumen 18 extending from a first opening adjacent the first end 12 to a second opening adjacent the second end 14 to allow passage of food, fluids, etc. therethrough.

[0078] The stent 50 can be expanded from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, the stent 50 can be deployed to a configuration between the collapsed configuration and the expanded configuration, that is, the stent 50 can be deployed with a deployment diameter that is larger than the diameter of the stent 50 or a specific portion thereof in its collapsed configuration, but still smaller than the diameter of the stent 50 or a specific portion thereof in its fully expanded configuration. In some cases, the anatomical structure in which the stent 50 is deployed may affect its deployment configuration. For example, if the diameter of the anatomical structure in which the stent 50 is to be deployed is smaller than the diameter of the stent 50 or a specific portion thereof when fully expanded, the deployment diameter of the stent 50 can be between its collapsed configuration diameter and its fully expanded configuration diameter.

[0079] In some cases, in the radial expansion configuration, the stent 50 may include a first end region 20 adjacent to the first end 12 and a second end region 22 adjacent to the second end 14. In some cases, as shown, the first end region 20 and the second end region 22 may include a retention feature or an anti-migration flared region with an expanded diameter relative to the middle region 16. The anti-migration flared region that can be positioned adjacent to the first end 12 and / or the second end 14 may be configured to engage the inner portion of the wall of the esophagus or other body cavity. In some cases, the diameter of the retention feature or flared region may be greater than the middle region 16 of the stent 50 to prevent the stent 50 from migrating once placed in the esophagus or other body cavity. In some cases, the transition from the cross-sectional area of ​​the middle region 16 to the retention feature or flared region may be gradual, inclined, or occur in a sudden stepped manner as required.

[0080] In some cases, the first anti-migration flared region may have a first outer diameter, and the second anti-migration flared region may have a second outer diameter. In some cases, the first outer diameter and the second outer diameter may be approximately the same, while in other cases, the first outer diameter and the second outer diameter may be different. In some cases, the stent 50 may include only one anti-migration flared region or may not include any anti-migration flared region. For example, the first end region 20 may include an anti-migration flare, while the second end region 22 may have an outer diameter similar to that of the middle region 16. It is also conceivable that the second end region 22 may include an anti-migration flare, while the first end region 20 may have an outer diameter similar to that of the middle region 16. In some embodiments, the stent 50 may have a uniform outer diameter from the first end 12 to the second end 14. In some embodiments, the outer diameter of the middle region 16 may be in the range of 15 to 25 mm in the fully expanded form. The outer diameter of the anti-migration flare may be in the range of 20 to 30 mm in the fully expanded form. It is conceivable that the outer diameter of the stent 50 may vary to suit the desired application.

[0081] In some cases, the flexibility of the stent 50 or at least a portion thereof can be increased by cutting or otherwise removing segments of some of the individual filaments. For example, the stent 50 includes a first void 52 and a second void 54. In some cases, the first void 52 and the second void 54 can be different voids. In some cases, the first void 52 and the second void 54 can actually be combined together on the back of the stent 50 (not shown). As will be discussed, in some cases, the stent 50 can include a plurality of voids extending at least partially around the stent 50 circumferentially, and the voids can be located at a plurality of axial positions (a plurality of spaced-apart rows) separated longitudinally along the stent 50.

[0082] The first void 52 and the second void 54 can extend circumferentially around the stent 50 at a first axial position of the stent 50, or if desired, each of the first void 52 and the second void 54 can extend circumferentially around the stent 50 at first and second axially spaced positions of the stent 50. The first void 52 and / or the second void 54 can extend circumferentially around any desired arc length of the circumference of the stent 50. For example, each of the first void 52 and / or the second void 54 can extend 30 degrees or more, 40 degrees or more, 45 degrees or more, 60 degrees or more, 75 degrees or more, 85 degrees or more, 90 degrees or more, 120 degrees or more, 150 degrees or more, or 180 degrees or more around the circumference of the stent 50.

[0083] Figure 4 An enlarged view of a portion of a stent 50 is provided. A stent 10 ( Figure 2 ), the stent 50 does not include any complete cells within the circumferential row of cells that include the first interstices 52 and the second interstices 54. Rather, at least on the visible portion of the stent 50, only a single filament 56 extending in the first helical direction and a single filament 58 extending in the second helical direction separate the first interstices 52 from the second interstices 54. It should be understood that, for example, with respect to, for example, Figure 3 and Figure 4 Compared to the interstices 30 and 32 shown in FIG. 5 , the support 50 has additional flexibility at least in the region of the first interstices 52 and the second interstices 54 .

[0084] Figure 56 is a side view of an illustrative intraluminal implant 60, such as, but not limited to, a stent. Stent 60 can take the form of an elongated tubular member, however, stent 60 can also take any desired cross-sectional shape. For example, stent 60 can have a braided structure made of a plurality of filaments, the plurality of filaments including a first plurality of filaments each extending in a first helical direction and a second plurality of filaments each extending in a second helical direction.

[0085] The stent 60 may have a first or proximal end 12, a second or distal end 14, and an intermediate region 16 disposed between the first and second ends 12, 14. The stent 60 may include a lumen 18 extending from a first opening adjacent the first end 12 to a second opening adjacent the second end 14 to allow food, fluids, etc. to pass therethrough.

[0086] The stent 60 can be expanded from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, the stent 60 can be deployed to a configuration between the collapsed configuration and the expanded configuration, that is, the stent 60 can be deployed with a deployment diameter that is larger than the diameter of the stent 60 or a specific portion thereof in its collapsed configuration, but still smaller than the diameter of the stent 60 or a specific portion thereof in its fully expanded configuration. In some cases, the anatomical structure in which the stent 60 is deployed may affect its deployment configuration. For example, if the diameter of the anatomical structure in which the stent 60 is to be deployed is smaller than the diameter of the stent 60 or a specific portion thereof when fully expanded, the deployment diameter of the stent 60 can be between its collapsed configuration diameter and its fully expanded configuration diameter.

[0087] In some cases, in the radial expansion configuration, the stent 60 may include a first end region 20 adjacent to the first end 12 and a second end region 22 adjacent to the second end 14. In some cases, as shown, the first end region 20 and the second end region 22 may include a retention feature or an anti-migration flared region with an enlarged diameter relative to the middle region 16. The anti-migration flared region that can be positioned adjacent to the first end 12 and / or the second end 14 may be configured to engage the inner portion of the wall of the esophagus or other body cavity. In some cases, the diameter of the retention feature or flared region may be greater than the middle region 16 of the stent 60 to prevent the stent 60 from migrating once placed in the esophagus or other body cavity. In some cases, the transition from the cross-sectional area of ​​the middle region 16 to the retention feature or flared region may be gradual, inclined, or occur in a sudden stepped manner as required.

[0088] In some cases, the first anti-migration flared region may have a first outer diameter, and the second anti-migration flared region may have a second outer diameter. In some cases, the first outer diameter and the second outer diameter may be approximately the same, while in other cases, the first outer diameter and the second outer diameter may be different. In some cases, the stent 60 may include only one anti-migration flared region or may not include any anti-migration flared region. For example, the first end region 20 may include an anti-migration flare, while the second end region 22 may have an outer diameter similar to that of the middle region 16. It is also conceivable that the second end region 22 may include an anti-migration flare, while the first end region 20 may have an outer diameter similar to that of the middle region 16. In some embodiments, the stent 60 may have a uniform outer diameter from the first end 12 to the second end 14. In some embodiments, the outer diameter of the middle region 16 may be in the range of 15 to 25 mm in the fully expanded form. The outer diameter of the anti-migration flare may be in the range of 20 to 30 mm in the fully expanded form. It is conceivable that the outer diameter of the stent 60 may vary to suit the desired application.

[0089] In some cases, the flexibility of the stent 60 or at least a portion thereof can be increased by cutting or otherwise removing segments of some of the individual filaments. For example, the stent 60 includes a first void 62 and a second void 64. In some cases, the first void 62 and the second void 64 can be different voids. In some cases, the first void 62 and the second void 64 can actually be combined together on the back of the stent 60 (not shown). As will be discussed, in some cases, the stent 60 can include a plurality of voids extending at least partially around the stent 60 circumferentially, and the voids can be located at a plurality of axial positions (a plurality of spaced-apart rows) separated longitudinally along the stent 60.

[0090] The first void 62 and the second void 64 can extend circumferentially around the stent 60 at a first axial position of the stent 60, or if desired, each of the first void 62 and the second void 64 can extend circumferentially around the stent 60 at first and second axially spaced positions of the stent 60. The first void 62 and / or the second void 64 can extend circumferentially around any desired arc length of the circumference of the stent 60. For example, each of the first void 62 and / or the second void 64 can extend 30 degrees or more, 40 degrees or more, 45 degrees or more, 60 degrees or more, 75 degrees or more, 85 degrees or more, 90 degrees or more, 120 degrees or more, 150 degrees or more, or 180 degrees or more around the circumference of the stent 60.

[0091] Figure 6An enlarged view of a portion of stent 60 is provided. As shown, stent 60 includes a total of three filaments 66a, 66b, and 66c extending in a first helical direction intersecting a circumferential row of cells including first voids 52 and second voids 54; and a total of three filaments 68a, 68b, and 68c extending in a second helical direction intersecting the same circumferential row of cells. Stent 60 may exhibit slightly less flexibility relative to stent 10 or stent 50, but may also exhibit additional strength.

[0092] Figure 7 70 is a side view of a portion of an illustrative stent 70, which includes a first or proximal region 72 and a second or distal region 74. The stent 70 can be expanded from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, the stent 70 can be deployed to a configuration between the collapsed configuration and the expanded configuration, that is, the stent 70 can be deployed with a deployment diameter that is larger than the diameter of the stent 70 or a specific portion thereof in its collapsed configuration, but still smaller than the diameter of the stent 70 or a specific portion thereof in its fully expanded configuration. In some cases, the anatomical structure in which the stent 70 is deployed may affect its deployment configuration. For example, if the diameter of the anatomical structure in which the stent 70 is to be deployed is smaller than the diameter of the stent 70 or a specific portion thereof when fully expanded, the deployment diameter of the stent 70 can be between its collapsed configuration diameter and its fully expanded configuration diameter.

[0093] In some cases, in the radially expanded configuration, the stent 70 can include an anti-migration flared region having an enlarged diameter relative to the shown portion of the stent 70. The anti-migration flared region, if present, can be configured to engage the inner portion of the wall of the esophagus or other body cavity. The anti-migration region with enlarged diameter can help prevent the stent 70 from migrating once placed in the esophagus or other body cavity. In some cases, the transition to the enlarged diameter can be gradual, oblique, or occur in an abrupt step-like manner, as desired.

[0094] In some cases, the first anti-migration flare region may have a first outer diameter and the second anti-migration flare region may have a second outer diameter. In some cases, the first outer diameter and the second outer diameter may be approximately the same, while in other cases, the first and second outer diameters may be different. In some cases, the stent 70 may include only one anti-migration flare region or may not include any anti-migration flare region. For example, the first end of the stent 70 may include an anti-migration flare, while the second end of the stent 70 may not include it. In some cases, the second end of the stent 70 may include an anti-migration flare, while the first end of the stent 70 does not include it. In the fully expanded form, the stent 70 may have an outer diameter in the range of 15 to 25 millimeters outside of any flare region. The outer diameter of any anti-migration flare may be in the range of 20 to 30 millimeters in the fully expanded form. It is conceivable that the outer diameter of the stent 70 may vary to suit the desired application.

[0095] In order to enhance the flexibility of the support 70, the support 70 includes a first gap 76 located in the proximal region 72 and a second gap 78 located in the proximal region 72. The first gap 76 and the second gap 78 can each extend only a short distance around the support 70 circumferentially. For example, each of the first gap 76 and / or the second gap 78 can extend between 10 degrees and 60 degrees or between 15 degrees and 50 degrees around the circumference of the support 70. However, in other cases, the first gap 76 and / or the second gap 78 can extend more than 60 degrees around the circumference of the support 70 or extend less than 10 degrees around the circumference of the support 70. In some cases, the first gap 76 and the second gap 78 extend all the way around the support 70 and are combined together on the back side (not shown) of the support 70. The support 70 includes a third gap 80 located in the distal region 74 and a fourth gap 82 located in the distal region 74. The third gap 80 and the fourth gap 82 can each extend only a short distance around the support 70 circumferentially. For example, each of the third void 80 and / or the fourth void 82 may extend between 10 and 60 degrees or between 15 and 50 degrees around the circumference of the bracket 70. However, in other cases, the third void 80 and / or the fourth void 82 may extend more than 60 degrees around the circumference of the bracket or less than 10 degrees around the circumference of the bracket 70. In some cases, the third void 80 and the fourth void 82 extend all the way around the bracket 70 and are joined together on the back side (not shown) of the bracket 70.

[0096] The relative sizes of the first interstices 76, the second interstices 78, the third interstices 80, and the fourth interstices 82 can vary, depending on the intended application of the stent 70. As shown, there are a total of two filaments 84a and 84b extending in the first helical direction and intersecting the circumferential rows of cells including the first interstices 76 and the second interstices 78, which are consistent with Figure 4In some cases, there may be three such filaments extending in the first helical direction and intersecting the circumferential row of cells, which is similar to Figure 6 . Alternatively, in some cases, there may be only a single filament that extends in the first helical direction and intersects the small grids of the circumferential row. For example, changing how many filaments remain after forming gaps 76 and 78 can affect the performance of the proximal region 72 of the stent 70.

[0097] Similarly, as shown, there are a total of two filaments 88a and 84b, which extend in the first helical direction and intersect the circumferential row of cells including the third and fourth interstices 80 and 82, which are consistent with Figure 2 In some cases, there may be three such filaments extending in the first helical direction and intersecting the circumferential row of cells, which is similar to Figure 6 Alternatively, in some cases, there may be only a single filament that extends in the first helical direction and intersects the circumferential row of cells, which is similar to Figure 4 For example, varying how many filaments remain after forming voids 80 and 82 can affect the performance of distal region 74 of stent 70.

[0098] Figure 8 94, a first or proximal region 94, a second or distal region 96, and an intermediate region 98 therebetween. The stent 92 can be expanded from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, the stent 92 can be deployed to a configuration between the collapsed configuration and the expanded configuration, that is, the stent 92 can be deployed with a deployment diameter that is larger than the diameter of the stent 92 or a specific portion thereof in its collapsed configuration, but still smaller than the diameter of the stent 92 or a specific portion thereof in its fully expanded configuration. In some cases, the anatomical structure in which the stent 92 is deployed may affect its deployment configuration. For example, if the diameter of the anatomical structure in which the stent 92 is to be deployed is smaller than the diameter of the stent 92 or a specific portion thereof when fully expanded, the deployment diameter of the stent 92 can be between its collapsed configuration diameter and its fully expanded configuration diameter.

[0099] In some cases, in the radially expanded configuration, the stent 92 can include an anti-migration flared region having an enlarged diameter relative to the shown portion of the stent 92. The anti-migration flared region, if present, can be configured to engage the inner portion of the wall of the esophagus or other body cavity. The anti-migration region with enlarged diameter can help prevent the stent 92 from migrating once placed in the esophagus or other body cavity. In some cases, the transition to the enlarged diameter can be gradual, oblique, or occur in an abrupt step-like manner, as desired.

[0100] In some cases, the first anti-migration flare region can have a first outer diameter and the second anti-migration flare region can have a second outer diameter. In some cases, the first outer diameter and the second outer diameter can be approximately the same, while in other cases, the first outer diameter and the second outer diameter can be different. In some cases, the stent 92 can include only one anti-migration flare region or not include any anti-migration flare region. For example, the first end of the stent 92 can include an anti-migration flare, while the second end of the stent 92 can not include it. In some cases, the second end of the stent 92 can include an anti-migration flare, while the first end of the stent 92 does not include it. In the fully expanded form, the stent 92 can have an outer diameter in the range of 15 to 25 millimeters outside of any flare region. The outer diameter of any anti-migration flare can be in the range of 20 to 30 millimeters in the fully expanded form. It is conceivable that the outer diameter of the stent 92 can be varied to suit the desired application.

[0101] In order to enhance the flexibility of the support 92, the support 92 includes a first gap 100 located in the proximal region 94 and a second gap 102 located in the proximal region 94. The first gap 100 and the second gap 102 can each extend only a short distance around the support 92 circumferentially. For example, each of the first gap 100 and / or the second gap 102 can extend between 10 degrees and 60 degrees or between 15 degrees and 50 degrees around the circumference of the support 92. However, in other cases, the first gap 100 and / or the second gap 102 can extend greater than 60 degrees around the circumference of the support 92 or extend less than 10 degrees around the circumference of the support 92. In some cases, the first gap 100 and the second gap 102 extend all the way around the support 92 and are combined together on the back side (not shown) of the support 92. The support 92 includes a third gap 104 located in the middle region 98 and a fourth gap 106 located in the middle region 98. The third gap 104 and the fourth gap 106 can each extend only a short distance around the circumference of the support 92. For example, each of the third gap 104 and / or the fourth gap 106 can extend between 10 degrees and 60 degrees or between 15 degrees and 50 degrees around the circumference of the support 92. However, in other cases, the third gap 104 and / or the fourth gap 106 can extend more than 60 degrees around the circumference of the support 92 or extend less than 10 degrees around the circumference of the support 92. In some cases, the third gap 104 and the fourth gap 106 extend all the way around the support 92 and are joined together on the back side (not shown) of the support 92. The support 92 includes a fifth gap 108 located in the distal region 96 and a sixth gap 110 located in the distal region 96. The fifth gap 108 and the sixth gap 110 can each extend only a short distance around the circumference of the support 92. For example, each of the fifth void 108 and / or the sixth void 110 may extend between 10 and 60 degrees or between 15 and 50 degrees around the circumference of the bracket 92. However, in other cases, the fifth void 108 and / or the sixth void 110 may extend more than 60 degrees around the circumference of the bracket 92 or less than 10 degrees around the circumference of the bracket 92. In some cases, the fifth void 108 and the sixth void 110 extend all the way around the bracket 92 and are joined together on the back side (not shown) of the bracket 92.

[0102] and Figure 7 Similar to the one shown, there are two filaments extending in the first spiral direction and two filaments extending in the second spiral direction, which intersect each row of cells in the circular row where the first gap 100 and the second gap 102, the third gap 104 and the fourth gap 106, and the first gap 108 and the sixth gap 110 are located. Figure 2 In some cases, there may be three such filaments extending in the first helical direction and intersecting each circumferential row of cells comprising voids, which is similar to Figure 6 Alternatively, in some cases, there may be only a single filament that extends in the first helical direction and intersects the circumferential row of cells, which is similar to Figure 4 Similar to that shown in .

[0103] Fig. 9 1 is a side view of a portion of an illustrative stent 112, which includes a first or proximal region 114, a second or distal region 116, and an intermediate region 118 therebetween. The stent 112 can be expanded from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, the stent 112 can be deployed to a configuration between the collapsed configuration and the expanded configuration, that is, the stent 112 can be deployed with a deployment diameter that is larger than the diameter of the stent 112 or a specific portion thereof in its collapsed configuration, but still smaller than the diameter of the stent 112 or a specific portion thereof in its fully expanded configuration. In some cases, the anatomical structure in which the stent 112 is deployed may affect its deployment configuration. For example, if the diameter of the anatomical structure in which the stent 112 is to be deployed is smaller than the diameter of the stent 112 or a specific portion thereof when fully expanded, the deployment diameter of the stent 112 can be between its collapsed configuration diameter and its fully expanded configuration diameter.

[0104] In some cases, in the radially expanded configuration, the stent 112 can include an anti-migration flared region having an enlarged diameter relative to the shown portion of the stent 112. The anti-migration flared region, if present, can be configured to engage the inner portion of the wall of the esophagus or other body cavity. The anti-migration region with enlarged diameter can help prevent the stent 112 from migrating once placed in the esophagus or other body cavity. In some cases, the transition to the enlarged diameter can be gradual, oblique, or occur in an abrupt step-like manner, as desired.

[0105] In some cases, the first anti-migration flare region may have a first outer diameter and the second anti-migration flare region may have a second outer diameter. In some cases, the first outer diameter and the second outer diameter may be approximately the same, while in other cases, the first outer diameter and the second outer diameter may be different. In some cases, the stent 112 may include only one anti-migration flare region or may not include any anti-migration flare region. For example, the first end of the stent 112 may include an anti-migration flare, while the second end of the stent 112 may not include it. In some cases, the second end of the stent 112 may include an anti-migration flare, while the first end of the stent 112 does not include it. In the fully expanded form, the stent 112 may have an outer diameter in the range of 15 to 25 millimeters outside of any flare region. The outer diameter of any anti-migration flare may be in the range of 20 to 30 millimeters in the fully expanded form. It is conceivable that the outer diameter of the stent 112 may vary to suit the desired application.

[0106] In order to enhance the flexibility of the stent 112, the stent 112 includes a plurality of small cells of flexible enhanced rows, wherein at least some of the small cells in each row of the flexible enhanced rows have been broken. The stent 112 includes a first flexible enhanced row 120 located in the proximal region 114 of the stent 112, a second flexible enhanced row 122 located in the middle region 118, a third flexible enhanced row 124 located in the middle region 118, and a fourth flexible enhanced row 126 located in the distal region 116. Although a total of four flexible enhanced rows 120, 122, 124, 126 are shown, it should be understood that this is merely illustrative, because the stent 112 can have any desired number of flexible enhanced rows, including five, six, seven, eight or more flexible enhanced rows. In some cases, the stent 112 can have less than four flexible enhanced rows.

[0107] As seen, the first flexible reinforcement row 120 includes a gap 120a and a gap 120b. The gaps 120a and 120b can each extend only a short distance around the bracket 112. In some cases, the gaps 120a and 120b can extend all the way around the bracket 112 and are combined together on the back side (not shown) of the bracket 112. The second flexible reinforcement row 122 includes a gap 122a and a gap 122b. The gaps 122a and 122b can each extend only a short distance around the bracket 112. In some cases, the gaps 122a and 122b can extend all the way around the bracket 112 and are combined together on the back side (not shown) of the bracket 112. The third flexible reinforcement row 124 includes a gap 124a and a gap 124b. The gaps 124a and 124b can each extend only a short distance around the bracket 112. In some cases, voids 124a and 124b can extend all the way around bracket 112 and be joined together on the back side (not shown) of bracket 112. Fourth flexibility enhancement row 126 includes voids 126a and voids 126b. Voids 126a and 126b can each extend only a short distance circumferentially around bracket 112. In some cases, voids 126a and 126b can extend all the way around bracket 112 and be joined together on the back side (not shown) of bracket 112.

[0108] The stent 112 includes a total of two filaments extending in a first helical direction and two filaments extending in a second helical direction, which intersect each of the circumferential rows of cells 120, 122, 124, and 126 of increased flexibility. Figure 2 In some cases, there may be three such filaments extending in the first helical direction and intersecting each circumferential row of cells comprising voids, which is similar to Figure 6Alternatively, in some cases, there may be only a single filament that extends in the first helical direction and intersects the circumferential row of cells, which is similar to Figure 4 Similar to that shown in .

[0109] Fig.10 1 is a side view of a portion of an illustrative stent 128, which includes a first or proximal region 114, a second or distal region 116, and an intermediate region 118 therebetween. The stent 128 can be expanded from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, the stent 128 can be deployed to a configuration between the collapsed configuration and the expanded configuration, that is, the stent 128 can be deployed with a deployment diameter that is larger than the diameter of the stent 128 or a specific portion thereof in its collapsed configuration, but still smaller than the diameter of the stent 128 or a specific portion thereof in its fully expanded configuration. In some cases, the anatomical structure in which the stent 128 is deployed may affect its deployment configuration. For example, if the diameter of the anatomical structure in which the stent 128 is to be deployed is smaller than the diameter of the stent 128 or a specific portion thereof when fully expanded, the deployment diameter of the stent 128 can be between its collapsed configuration diameter and its fully expanded configuration diameter.

[0110] In some cases, in the radially expanded configuration, the stent 128 can include an anti-migration flared region having an enlarged diameter relative to the illustrated portion of the stent 128. The anti-migration flared region, if present, can be configured to engage an interior portion of the wall of the esophagus or other body cavity. The anti-migration region with enlarged diameter can help prevent the stent 128 from migrating once placed in the esophagus or other body cavity. In some cases, the transition to the enlarged diameter can be gradual, oblique, or occur in an abrupt, stepped manner, as desired.

[0111] In some cases, the first anti-migration flare region can have a first outer diameter and the second anti-migration flare region can have a second outer diameter. In some cases, the first and second outer diameters can be approximately the same, while in other cases, the first and second outer diameters can be different. In some cases, the stent 128 can include only one anti-migration flare region or not include any anti-migration flare region. For example, the first end of the stent 128 can include an anti-migration flare while the second end of the stent 128 can not. In some cases, the second end of the stent 128 can include an anti-migration flare while the first end of the stent 128 does not. In the fully expanded configuration, the stent 128 can have an outer diameter in the range of 15 to 25 millimeters outside of any flare region. The outer diameter of any anti-migration flare can be in the range of 20 to 30 millimeters in the fully expanded configuration. It is conceivable that the outer diameter of the stent 128 can vary to suit the desired application.

[0112] In order to enhance the flexibility of the bracket 128, the bracket 128 includes a plurality of flexible reinforcing rows of cells, wherein at least some of the cells within each row of the flexible reinforcing rows have been broken. The bracket 128 includes a first flexible reinforcing row 130, a second flexible reinforcing row 132, a third flexible reinforcing row 134, a fourth flexible reinforcing row 136, a fifth flexible reinforcing row 138, and a sixth flexible reinforcing row 140. Although a total of six flexible reinforcing rows 130, 132, 134, 136, 138, and 140 are shown, it should be understood that this is merely illustrative, as the bracket 128 can have any desired number of flexible reinforcing rows, including five, six, seven, eight, or more flexible reinforcing rows. In some cases, the bracket 128 can have less than six flexible reinforcing rows.

[0113] As seen, the first flexible reinforcement row 130 includes a gap 130a and a gap 130b. The gaps 130a and 130b can each extend only a short distance around the bracket 128. In some cases, the gaps 130a and 130b can extend all the way around the bracket 128 and are combined together on the back side (not shown) of the bracket 128. The second flexible reinforcement row 132 includes a gap 132a and a gap 132b. The gaps 132a and 132b can each extend only a short distance around the bracket 128. In some cases, the gaps 132a and 132b can extend all the way around the bracket 128 and are combined together on the back side (not shown) of the bracket 112. The third flexible reinforcement row 134 includes a gap 134a and a gap 134b. The gaps 134a and 134b can each extend only a short distance around the bracket 128. In some cases, voids 134a and 134b may extend all the way around bracket 128 and join together on a back side (not shown) of bracket 128 .

[0114] Fourth flexible enhancement row 136 includes gap 136a and gap 136b. Gaps 136a and 136b can each extend only a short distance around bracket 128. In some cases, gaps 136a and 136b can extend all the way around bracket 112 and be combined together on the back side (not shown) of bracket 112. Fifth flexible enhancement row 138 includes gap 138a and gap 138b. Gaps 138a and 138b can each extend only a short distance around bracket 128. In some cases, gaps 138a and 138b can extend all the way around bracket 112 and be combined together on the back side (not shown) of bracket 112. Sixth flexible enhancement row 140 includes gap 140a and gap 140b. Gaps 140a and 140b can each extend only a short distance around bracket 128. In some cases, voids 140a and 140b may extend all the way around bracket 112 and join together on a back side (not shown) of bracket 112 .

[0115] The stent 128 includes a total of two filaments extending in a first helical direction and two filaments extending in a second helical direction that intersect each of the flexibility enhancement rows 130, 132, 134, 136, 138, and 140. This is similar to Figure 2 In some cases, there may be three such filaments extending in the first helical direction and intersecting each circumferential row of cells comprising voids, which is similar to Figure 6 Alternatively, in some cases, there may be only a single filament that extends in the first helical direction and intersects the circumferential row of cells, which is similar to Figure 4 Similar to that shown in .

[0116] Fig.11 1 is a side view of an illustrative intraluminal implant 142, such as, but not limited to, a stent. Stent 142 can take the form of an elongated tubular member, however, stent 142 can also take any desired cross-sectional shape. For example, stent 142 can have a braided structure made of a plurality of filaments, the plurality of filaments including a first plurality of filaments each extending in a first helical direction and a second plurality of filaments each extending in a second helical direction.

[0117] The bracket 142 can have a first or proximal end 114, a second or distal end 116, and an intermediate region 118 disposed between the first end 114 and the second end 116. The bracket 142 can include a cavity 144 extending from a first opening adjacent to the first end 114 to a second opening adjacent to the second end 116 to allow food, fluids, etc. to pass therethrough.

[0118] The stent 142 can be expanded from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, the stent 142 can be deployed to a configuration between the collapsed configuration and the expanded configuration, that is, the stent 142 can be deployed with a deployment diameter that is larger than the diameter of the stent 142 or a specific portion thereof in its collapsed configuration, but still smaller than the diameter of the stent 142 or a specific portion thereof in its fully expanded configuration. In some cases, the anatomical structure in which the stent 142 is deployed may affect its deployment configuration. For example, if the diameter of the anatomical structure in which the stent 142 is to be deployed is smaller than the diameter of the stent 142 or a specific portion thereof when fully expanded, the deployment diameter of the stent 142 can be between its collapsed configuration diameter and its fully expanded configuration diameter.

[0119] As shown, in the radially expanded configuration, stent 142 can include an anti-migration flared region having an enlarged diameter relative to the shown portion of stent 142. The anti-migration flared region, if present, can be configured to engage the inner portion of the wall of the esophagus or other body cavity. The anti-migration region with enlarged diameter can help prevent the stent 142 from migrating once placed in the esophagus or other body cavity. In some cases, the transition to the enlarged diameter can be gradual, oblique, or occur in a sudden stepped manner, as desired.

[0120] In some cases, the first anti-migration flare region may have a first outer diameter and the second anti-migration flare region may have a second outer diameter. In some cases, the first outer diameter and the second outer diameter may be approximately the same, while in other cases, the first outer diameter and the second outer diameter may be different. In some cases, the stent 142 may include only one anti-migration flare region or may not include any anti-migration flare region. For example, the first end of the stent 142 may include an anti-migration flare, while the second end of the stent 142 may not include it. In some cases, the second end of the stent 142 may include an anti-migration flare, while the first end of the stent 142 does not include it. In the fully expanded form, the stent 142 may have an outer diameter in the range of 15 to 25 millimeters outside of any flare region. The outer diameter of any anti-migration flare may be in the range of 20 to 30 millimeters in the fully expanded form. It is conceivable that the outer diameter of the stent 142 may vary to suit the desired application.

[0121] In some cases, as shown, the stent 142 can be considered to include an elongated tubular member 146 and a polymer covering 148 (shown via a dotted pattern) covering the elongated tubular member 146. The polymer covering 148 can be applied to the elongated tubular member 146 via dipping or spraying. The elongated tubular member 146 includes a constant diameter section 148, a first flared section 150, and a second flared section 152. The constant diameter section 148 is different from the first flared section 150 and the second flared section 152, wherein a void space 154 is disposed between the first flared section 150 and the constant diameter section 148, and a void space 156 is disposed between the constant diameter section 148 and the second flared section 152.

[0122] In some cases, the constant diameter section 148, the first flared section 150, and the second flared section 152 may be independently woven with a first plurality of filaments extending in a first spiral direction and a second plurality of filaments extending in a second spiral direction. In some cases, before the elongated tubular member 146 is cut into different constant diameter sections 148, the first flared section 150, and the second flared section 152, the elongated tubular member 146 may be woven into a unitary member, wherein the same filaments extend through each of the first flared section 150, the constant diameter section 148, and the second flared section 152. It should be understood that the stent 142 will have improved flexibility due to the first void space 154 and the second void space 156 that allow the constant diameter section 148, the first flared section 150, and the second flared section 152 to bend independently of each other. The polymer covering 148 extends across each of the first void space 154 and the second void space 156.

[0123] Fig.12 1 is a side view of an illustrative intraluminal implant 158, such as, but not limited to, a stent. Stent 158 ​​can take the form of an elongated tubular member, however stent 158 ​​can also take any desired cross-sectional shape. For example, stent 158 ​​can have a braided structure made of a plurality of filaments, the plurality of filaments including a first plurality of filaments each extending in a first helical direction and a second plurality of filaments each extending in a second helical direction.

[0124] The bracket 158 ​​can have a first or proximal end 114, a second or distal end 116, and an intermediate region 118 disposed between the first end 114 and the second end 116. The bracket 158 ​​can include a cavity 144 extending from a first opening adjacent to the first end 114 to a second opening adjacent to the second end 116 to allow food, fluids, etc. to pass therethrough.

[0125] Stent 158 ​​can be expanded from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, stent 158 ​​can be deployed to a configuration between the collapsed configuration and the expanded configuration, that is, stent 158 ​​can be deployed with a deployment diameter that is larger than the diameter of stent 158 ​​or a specific portion thereof in its collapsed configuration, but still smaller than the diameter of stent 158 ​​or a specific portion thereof in its fully expanded configuration. In some cases, the anatomical structure in which stent 158 ​​is deployed may affect its deployment configuration. For example, if the diameter of the anatomical structure in which stent 158 ​​is to be deployed is smaller than the diameter of stent 158 ​​or a specific portion thereof when fully expanded, the deployment diameter of stent 158 ​​can be between its collapsed configuration diameter and its fully expanded configuration diameter.

[0126] As shown, in the radially expanded configuration, stent 158 ​​can include an anti-migration flared region having an enlarged diameter relative to the shown portion of stent 158. The anti-migration flared region, if present, can be configured to engage the inner portion of the wall of the esophagus or other body cavity. The anti-migration region with enlarged diameter can help prevent the stent 158 ​​from migrating once it is placed in the esophagus or other body cavity. In some cases, the transition to the enlarged diameter can be gradual, inclined, or occur in a sudden stepped manner, as desired.

[0127] In some cases, the first anti-migration flare region may have a first outer diameter and the second anti-migration flare region may have a second outer diameter. In some cases, the first outer diameter and the second outer diameter may be approximately the same, while in other cases, the first outer diameter and the second outer diameter may be different. In some cases, the stent 158 ​​may include only one anti-migration flare region or may not include any anti-migration flare region. For example, the first end of the stent 158 ​​may include an anti-migration flare, while the second end of the stent 158 ​​may not include it. In some cases, the second end of the stent 158 ​​may include an anti-migration flare, while the first end of the stent 158 ​​does not include it. In the fully expanded form, the stent 158 ​​may have an outer diameter in the range of 15 to 25 mm outside of any flare region. The outer diameter of any anti-migration flare may be in the range of 20 to 30 mm in the fully expanded form. It is conceivable that the outer diameter of the stent 158 ​​may vary to suit the desired application.

[0128] In some cases, as shown, the stent 158 ​​can be considered to include an elongated tubular member 160 and a polymer covering 162 (shown via a dotted pattern) covering the elongated tubular member 160. The polymer covering 162 can be applied to the elongated tubular member 160 via dipping or spraying. The elongated tubular member 160 includes an intermediate section (e.g., a constant diameter section 164), a first end section (e.g., a first flared section 166), and a second end section (e.g., a second flared section 168), wherein the intermediate section is positioned between the first end section and the second end section and is spaced apart from it. The intermediate section may not overlap with the first end section and / or the second end section, so that a circumferential gap extending completely around the circumference of the stent 158 ​​is provided between them. The constant diameter section 164 is different from the first flared section 166 and the second flared section 168.

[0129] In some cases, the constant diameter section 164, the first flared section 166, and the second flared section 168 may be independently braided with a first plurality of filaments extending in a first spiral direction and a second plurality of filaments extending in a second spiral direction. In some cases, before the elongated tubular member 160 is cut into different constant diameter sections 164, the first flared section 166, and the second flared section 168, the elongated tubular member 160 may be braided into a unitary member, wherein the same filaments extend through each of the first flared section 166, the constant diameter section 164, and the second flared section 168. It should be understood that since the constant diameter section 164, the first flared section 166, and the second flared section 168 can move independently of each other, the stent 158 ​​will have improved flexibility.

[0130] Fig. 12A Shown in Fig.12 164 and 166. The first flared section 166 includes a last row 170, which includes small cells 170a, 170b, and 170c. The constant diameter section 164 includes a last row 172, which includes small cells 172a and 172b. In some cases, as shown, the last row 172 is slightly spaced from the last row 170, thereby providing a circumferential gap extending completely around the bracket 158 ​​between the first flared section 166 and the constant diameter section 164, and similarly, the last row of the second flared section 168 is spaced from the last row of the constant diameter section 164, thereby providing a circumferential gap extending completely around the bracket 158 ​​between the second flared section 168 and the constant diameter section 164. The cells 172a, 172b within the last row 172 are circumferentially offset from the cells 170a, 170b, 170c within the last row 170, which would allow the cells 172a, 172b to be nested between the cells 170a, 170b, 170c if the last row 170 and the last row 172 were closer together. For example, the peaks of the last row 170 may be longitudinally aligned with the valleys of the last row 172, and thus the valleys of the last row 170 may be longitudinally aligned with the peaks of the last row 172. Thus, each peak of the last row 170 may be circumferentially positioned between each peak of the last row 172, and each valley of the last row 170 may be circumferentially positioned between each valley of the last row 172. A similar arrangement may exist between the second flared section 168 and the constant diameter section 164.

[0131] In some cases, the stent 158 ​​includes a fixing element 174 that combines the last row 170 and the last row 172 together. As can be seen, the fixing element 174 can extend circumferentially around the circumference of the stent 158, while the fixing element 174 passes in and out of the small grids of the last row 170 and the last row 172 so as to fix the first flared section 166 to the constant diameter section 164. When the fixing element crosses back and forth between the first flared section 166 and the constant diameter section 164, the fixing element 174 can meander back and forth across the circumferential gap. Although not shown in an enlarged manner, the constant diameter section 164 can be fixed to the second flared section 168 in a similar manner. In some cases, the fixing element 174 can be a filament (e.g., a wire, a line or a suture) that can be used to sew the stent segments together substantially. It should be understood that the polymer covering 162 can also help to keep the stent segments together.

[0132] Fig.13 is a side view of a portion of illustrative example 180, and Fig.13A It is along Fig.13 13A-13A of the schematic cross section thereof. Stent 180 can be expanded from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. Stent 180 can be considered to include a first region 182 and a second region 184. In some cases, stent 180 can be deployed to a configuration between the collapsed configuration and the expanded configuration, that is, stent 180 can be deployed with a deployment diameter that is larger than the diameter of stent 180 or a specific portion thereof in its collapsed configuration, but still smaller than the diameter of stent 180 or a specific portion thereof in its fully expanded configuration. In some cases, the anatomical structure in which stent 180 is deployed may affect its deployment configuration. For example, if the diameter of the anatomical structure in which stent 180 is to be deployed is smaller than the diameter of stent 180 or a specific portion thereof when fully expanded, the deployment diameter of stent 180 can be between its collapsed configuration diameter and its fully expanded configuration diameter.

[0133] In some cases, in the radially expanded configuration, stent 180 can include an anti-migration flared region having an enlarged diameter relative to the shown portion of stent 180. The anti-migration flared region, if present, can be configured to engage the inner portion of the wall of the esophagus or other body cavity. The anti-migration region with enlarged diameter can help prevent the stent 180 from migrating once placed in the esophagus or other body cavity. In some cases, the transition to the enlarged diameter can be gradual, oblique, or occur in an abrupt step-like manner, as desired.

[0134] In some cases, the first anti-migration flare region may have a first outer diameter and the second anti-migration flare region may have a second outer diameter. In some cases, the first and second outer diameters may be approximately the same, while in other cases, the first and second outer diameters may be different. In some cases, stent 180 may include only one anti-migration flare region or may not include any anti-migration flare region. For example, the first end of stent 180 may include an anti-migration flare while the second end of stent 180 may not. In some cases, the second end of stent 180 may include an anti-migration flare while the first end of stent 180 does not. In the fully expanded form, stent 180 may have an outer diameter in the range of 15 to 25 millimeters outside of any flare region. The outer diameter of any anti-migration flare may be in the range of 20 to 30 millimeters in the fully expanded form. It is conceivable that the outer diameter of stent 180 may vary to suit the desired application.

[0135] To enhance the flexibility of the stent 180, the stent 180 includes a first flexibility enhancement row 186 located in a first region 182 of the stent 180 and a second flexibility enhancement row 188 located in a second region 184 of the stent 180. The stent 180 may also include additional flexibility enhancement rows. The polymer cover 192 extends circumferentially around the stent 180. Fig.13A 188a, 188b, and 188c, which are disposed between support wall segments 190a, 190b, and 190c. Although each of the gaps 188a, 188b, and 188c shown in the figure has an arc length that is approximately the same as the arc length of each of the support wall segments 190a, 190b, and 190c, this is merely an example. In some cases, the gaps 188a, 188b, and 188c may be relatively long, and the support wall segments 190a, 190b, and 190c may be relatively short. In some cases, the gaps 188a, 188b, and 188c may be relatively short, and the support wall segments 190a, 190b, and 190c may be relatively long. It should be understood that the first flexible enhancement row 186 similarly includes a total of three gaps, however, only a single gap 186a is visible in this orientation. The first flexibility enhancement row 186 includes a total of three support wall segments, however only two support wall segments 194a and 194b are visible in this orientation.

[0136] Fig.14 is a side view of an illustrative bracket 196, Fig.14A It is along Fig.14 A schematic cross-section of the stent 196 taken along line 14A-14A of FIG. 14A and FIG. 14B . Fig. 14B It is along Fig.1414B-14B of the embodiment of the present invention. The support 196 can have a first or proximal end 114, a second or distal end 116, and an intermediate region 118 disposed between the first end 114 and the second end 116. The support 196 can include a cavity 144 extending from a first opening adjacent to the first end 114 to a second opening adjacent to the second end 116 to allow food, fluids, etc. to pass therethrough.

[0137] Stent 196 can be expanded from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, stent 196 can be deployed to a configuration between the collapsed configuration and the expanded configuration, i.e., stent 196 can be deployed with a deployment diameter that is larger than the diameter of stent 196 or a specific portion thereof in its collapsed configuration, but still smaller than the diameter of stent 196 or a specific portion thereof in its fully expanded configuration. In some cases, the anatomical structure in which stent 196 is deployed may affect its deployment configuration. For example, if the diameter of the anatomical structure in which stent 196 is to be deployed is smaller than the diameter of stent 196 or a specific portion thereof when fully expanded, the deployment diameter of stent 196 can be between its collapsed configuration diameter and its fully expanded configuration diameter.

[0138] As shown, in the radially expanded configuration, stent 196 can include an anti-migration flared region having an enlarged diameter relative to the shown portion of stent 196. The anti-migration flared region, if present, can be configured to engage the inner portion of the wall of the esophagus or other body cavity. The anti-migration region with enlarged diameter can help prevent the stent 196 from migrating once it is placed in the esophagus or other body cavity. In some cases, the transition to the enlarged diameter can be gradual, oblique, or occur in a sudden stepped manner, as desired.

[0139] In some cases, the first anti-migration flare region may have a first outer diameter and the second anti-migration flare region may have a second outer diameter. In some cases, the first outer diameter and the second outer diameter may be approximately the same, while in other cases, the first and second outer diameters may be different. In some cases, stent 196 may include only one anti-migration flare region or may not include any anti-migration flare region. For example, the first end of stent 196 may include an anti-migration flare while the second end of stent 196 may not include it. In some cases, the second end of stent 196 may include an anti-migration flare while the first end of stent 196 does not include it. In the fully expanded form, stent 196 may have an outer diameter in the range of 15 to 25 millimeters outside of any flare region. The outer diameter of any anti-migration flare may be in the range of 20 to 30 millimeters in the fully expanded form. It is conceivable that the outer diameter of stent 196 may vary to suit the desired application.

[0140] To increase the flexibility of the bracket 196, the bracket 196 includes a first flexibility enhancement row 198, a second flexibility enhancement row 200, a third flexibility enhancement row 202, a fourth flexibility enhancement row 204, and a fifth flexibility enhancement row 206. The bracket 196 may include additional flexibility enhancement rows. In some cases, the bracket 196 may include fewer flexibility enhancement rows. In some cases, as shown, each flexibility enhancement row 198, 200, 202, 204, 206 is circumferentially rotated relative to the adjacent flexibility enhancement rows 198, 200, 202, 204, 206. Because Fig.14A is a cross-sectional view taken through the flexible reinforcement row 202, and Fig. 14B 2 is a cross-sectional view taken through the flexibility enhancement row 204 so that the relative rotation between adjacent flexibility enhancement rows can be easily seen.

[0141] In comparison Fig.14A and Fig. 14B , it can be easily seen that the flexibility enhancement row 204 is rotated clockwise relative to the flexibility enhancement row 202. Each of the flexibility enhancement rows 198, 200, 202, 204, 206 includes a number of gaps and a number of intermediate stent wall segments. The gaps can be viewed as windows cut into the stent 196, such as cut via laser cutting or sawing. The windows formed in the stent 196 can be cut independently of the location of the intersection and can, for example, be a straight line shape rather than having to cut each filament adjacent to the intersection of a particular filament and another filament. Other shapes are also contemplated. The polymer covering 216 enclosing the stent 196 can be viewed as extending through the gaps or windows cut into the stent 196.

[0142] For illustration, first flexibility enhancement row 198 has a pair of visible gaps 198b and 198c (with third gap 198a positioned out of view behind bracket 198, with single bracket wall segment 206 visible between gap 198b and gap 198c). Second flexibility enhancement row 200 has a single gap 200a visible between bracket wall segment 208a and bracket wall segment 208b.

[0143] The third flexibility enhancement row 202 has a pair of visible gaps 202b and 202c (where the third gap 202a is positioned out of sight behind the bracket 198, and where a single bracket wall segment 210 is visible between gap 202b and gap 202c). The fourth flexibility enhancement row 204 has a single gap 240a visible between bracket wall segments 212a and 212b. The fifth flexibility enhancement row 206 has a pair of visible gaps 206b and 202c (where the third gap 206a is positioned out of sight behind the bracket 198, and where a single bracket wall segment 214 is visible between gap 206b and gap 206c).

[0144] As shown, the arc length of the bracket wall segments, including each of the bracket wall segments 212a, 212b, 212c, 206, 210, and 214, is less than the arc length of the gaps dispersed between each of the bracket wall segments 212a, 212b, 212c, 206, 210, and 214. In some cases, the arc length of the bracket wall segments, including each of the bracket wall segments 212a, 212b, 212c, 206, 210, and 214, can be approximately equal to the arc length of the gaps dispersed between each of the bracket wall segments 212a, 212b, 212c, 206, 210, and 214. In some cases, the arc length of the bracket wall segments, including each of the bracket wall segments 212a, 212b, 212c, 206, 210, and 214, is greater than the arc length of the gaps dispersed between each of the bracket wall segments 212a, 212b, 212c, 206, 210, and 214.

[0145] Fig.15 2 is a side view of a portion of an illustrative stent 220. Stent 220 includes a first segment 222, a second segment 224, and a third segment 226. Each of first segment 222, second segment 224, and third segment 226 can be formed by braiding together a first plurality of filaments extending in a first helical direction and a second plurality of filaments extending in a second helical direction before free cutting each of first segment 222, second segment 224, and third segment 226. In some cases, each of first segment 222, second segment 224, and third segment 226 can be formed separately by braiding together a first plurality of filaments extending in a first helical direction and a second plurality of filaments extending in a second helical direction to form first segment 222, and braiding together a first plurality of filaments extending in a first helical direction and a second plurality of filaments extending in a second helical direction to form second segment 224, and also braiding together a first plurality of filaments extending in a first helical direction and a second plurality of filaments extending in a second helical direction to form third segment 226. In either case, polymer cover 228 encloses stent 220.

[0146] Fig.15A2 is an enlarged view of a portion of the support 220, which shows the relationship between the first section 222 and the second section 224. The first section 222 includes a bottom row 230, which includes (as visible) cells 230a, cells 230b, and cells 230c. The second section 224 includes a bottom row 232, which has (as shown) cells 232a and cells 232b. It should be understood that the bottom row 230 and the bottom row 232 and the cells forming these bottom rows continue circumferentially around the support 220. It should be understood that the cells 232a, 232b in the bottom row 232 are circumferentially offset from the cells 230a, 230b, 230c in the bottom row 230. This allows the cells 232a, 232b to be nested between the cells 230a, 230b, 230c. Thus, the peaks of the last row 230 of the first segment 222 can be located closer to the third segment 226 than the peaks of the last row 232 of the second segment 224. For example, the peaks of the last row 230 can be longitudinally aligned with the valleys of the last row 232, and thus the valleys of the last row 230 can be longitudinally aligned with the peaks of the last row 232. Thus, each peak of the last row 230 can be circumferentially positioned between each peak of the last row 232, and each valley of the last row 230 can be circumferentially positioned between each valley of the last row 232. Similar configurations and arrangements can be provided between the second segment 224 and the third segment 226.

[0147] Fig.16 2 is a side view of a portion of an illustrative stent 234. Stent 234 includes a first segment 236, a second segment 238, and a third segment 240, which are coupled together via a polymer covering 242 (shown via a dotted pattern). Fig.15 different, Fig.16 The segments 236, 238 and 240 may not share a braiding pattern. As shown, the first segment 236 and the third segment 240 have similar (if not identical) braiding patterns, while the second segment 238 has a different braiding pattern, wherein fewer filaments are braided together, thereby forming a second segment 238 with a larger size grid between adjacent filaments. In this particular case, the first segment 236 and the third segment 240 can be formed by braiding together the first multiple filaments extending in the first spiral direction and the second multiple filaments extending in the second spiral direction before free cutting each of the first segment 236 and the third segment 240. The second segment 238 can be braided separately. In some cases, each segment in the first segment 236, the second segment 238 and the third segment 240 can be braided separately before being assembled together.

[0148] In some cases, the last row of the second segment 238 adjacent to the first segment 236 can include cells nested between cells in the last row of the first segment 236. For example, the peaks of the last row of the second segment 238 adjacent to the first segment 236 can be longitudinally aligned with the valleys of the last row of the first segment 236. As shown, the last row of the second segment 238 can include fewer peaks than the last row of the first segment 236, such that not every valley of the last row of the first segment 236 receives a peak of the last row of the second segment 238. Thus, each peak of the last row of the second segment 238 can be circumferentially positioned between adjacent peaks of the last row of the first segment 236. Other configurations are also contemplated.

[0149] In some cases, the last row of the second segment 238 adjacent to the third segment 240 can include cells nested between cells in the last row of the third segment 240. For example, the peaks of the last row of the second segment 238 adjacent to the third segment 240 can be longitudinally aligned with the valleys of the last row of the third segment 240. As shown, the last row of the second segment 238 can include fewer peaks than the last row of the third segment 240, such that not every valley of the last row of the third segment 240 receives a peak of the last row of the second segment 238. Thus, each peak of the last row of the second segment 238 can be circumferentially positioned between adjacent peaks of the last row of the third segment 240. Other configurations are also contemplated.

[0150] Fig.17 244 is a side view of a portion of an illustrative stent 244. Stent 244 includes a first segment 246, a second segment 248, and a third segment 250, which are connected together via a polymer covering 252 (shown via a dotted pattern). In this particular example, each of the first segment 246, the second segment 248, and the third segment 250 shares a similar braiding pattern, but uses different filaments. The filaments used to form the first segment 246 are lighter than the filaments used to form the second segment 248. Similarly, the filaments used to form the second segment 248 are lighter than the filaments used to form the third segment 250. Therefore, it should be understood that each segment will have different properties. In some cases, the braiding pattern can be changed by changing one or more of the wire count, wire diameter, braiding angle, etc.

[0151] In some cases, the last row of the second segment 248 adjacent to the first segment 246 can include cells nested between cells in the last row of the first segment 246. For example, the peaks of the last row of the second segment 248 adjacent to the first segment 246 can be longitudinally aligned with the valleys of the last row of the first segment 246. Thus, each peak of the last row of the second segment 248 can be circumferentially positioned between adjacent peaks of the last row of the first segment 246. Other configurations are also contemplated.

[0152] In some cases, the last row of the second segment 248 adjacent to the third segment 250 can include cells nested between cells in the last row of the third segment 250. For example, the peaks of the last row of the second segment 248 adjacent to the third segment 250 can be longitudinally aligned with the valleys of the last row of the third segment 250. Thus, each peak of the last row of the second segment 248 can be circumferentially positioned between adjacent peaks of the last row of the third segment 250. Other configurations are also contemplated.

[0153] Fig.18 2 is a side view of a portion of an illustrative stent 254. Stent 254 includes a first segment 256, a second segment 258, and a third segment 260, which are coupled together via a polymer covering 262 (shown via a dotted pattern). In this particular example, first segment 256 and third segment 260 share a similar braid pattern, but second segment 258 has a different braid pattern in which a greater number of filaments are braided together. It should be understood that second segment 258 will have different properties than those of first segment 256 and third segment 260.

[0154] In some cases, the last row of the second segment 258 adjacent to the first segment 256 can include cells nested between cells in the last row of the first segment 256. For example, the peaks of the last row of the second segment 258 adjacent to the first segment 256 can be longitudinally aligned with the valleys of the last row of the first segment 256. Thus, each peak of the last row of the second segment 258 can be circumferentially positioned between adjacent peaks of the last row of the first segment 256. Other configurations are also contemplated.

[0155] In some cases, the last row of the second segment 258 adjacent to the third segment 260 can include cells nested between cells in the last row of the third segment 260. For example, the peaks of the last row of the second segment 258 adjacent to the third segment 260 can be longitudinally aligned with the valleys of the last row of the third segment 260. Thus, each peak of the last row of the second segment 258 can be circumferentially positioned between adjacent peaks of the last row of the third segment 260. Other configurations are also contemplated.

[0156] Fig.19 264, 266, and 268 are connected together via a polymer covering 270 (shown via a dotted pattern). In this particular example, the three segments 264, 266, and 268 share a similar weave pattern, but the relationship between the three segments 264, 266, and 268 is similar to Figures 15 to 18 The ones shown in are slightly different. Fig.19 , the braid pattern has been slightly modified to provide a more atraumatic end to each of the segments 264, 266, 268, rather than having a rather abrupt transition between adjacent segments.

[0157] Fig.19A2 is an enlarged view of a portion of the bracket 262, which shows the relationship between the first section 264 and the second section 266. The first section 264 includes a bottom row 272, which includes (as shown) a small cell 272a, a small cell 272b, and a small cell 272c. The second section 264 includes a bottom row 274, which includes (as shown) a small cell 274a and a small cell 274b. It should be understood that the bottom row 272 and the bottom row 274 and the small cells forming these bottom rows continue circumferentially around the bracket 262. It should be understood that the small cells 274a and 274b in the bottom row 274 are circumferentially offset from the small cells 272a, 272b, and 272c in the bottom row 272. This allows the small cells 274a, 274b to be nested between the small cells 272a, 272b, 272c. For example, the peaks of the last row 272 may be longitudinally aligned with the valleys of the last row 274, and thus the valleys of the last row 272 may be longitudinally aligned with the peaks of the last row 274. Thus, each peak of the last row 272 may be circumferentially positioned between each peak of the last row 274, and each valley of the last row 272 may be circumferentially positioned between each valley of the last row 274. Additionally, each of the cells 272a, 272b, 272c within the last row 272 and the cells 274a and 274b within the last row 272 have been modified to have more gently curved, atraumatic edges.

[0158] Fig. 20 is a side view of a portion of an illustrative bracket 276, and Fig. 20A is an enlarged view of a portion thereof. Bracket 276 includes a first section 278, a second section 280, and a third section 282, which are at least partially coupled together via a polymer covering 284 (shown via a dotted pattern). Bracket 276 is similar in some ways to Fig.15 220 shown in . However, stent 276 includes fixation elements 286 and 288 extending circumferentially around the circumference of stent 276, which weave back and forth so that first segment 278 is adjacent to second segment 80, and second segment 280 is adjacent to third segment 282, respectively. In some cases, fixation elements 286 and 288 can be, for example, filaments (e.g., wires, threads, or sutures). As shown, for example, in Fig. 20A As can be seen in FIG. 2 , the fixation elements 288 (as well as the fixation elements 286 ) extend circumferentially around the circumference of the stent 276 , with the fixation elements 288 (as well as the fixation elements 286 ) weaving back and forth through the cells to abut adjacent segments.

[0159] It should be understood that the present invention is in many respects merely illustrative. Changes may be made in details, particularly in matters of arrangement of shape, size and steps, without exceeding the scope of the present invention. To the extent appropriate, this may include using any of the features of an example embodiment used in other embodiments. Of course, the scope of the present invention is defined by the language of the appended claims.

Claims

1. A bracket, comprising: an elongated tubular member expandable from a radially collapsed configuration to a radially expanded configuration, the elongated tubular member comprising a first plurality of filaments extending in a first helical direction and a second plurality of filaments extending in a second helical direction, the first plurality of filaments extending in the first helical direction and the second plurality of filaments extending in the second helical direction overlapping to form a plurality of cells arranged in a plurality of rows extending circumferentially around the elongated tubular member; Wherein at least some of the cells within the one or more rows are adapted to provide increased flexibility to the support.

2. The stent of claim 1, wherein at least some of the first plurality of filaments and at least some of the second plurality of filaments in one or more of the plurality of rows are cut to break at least some of the cells, thereby increasing the flexibility of the stent.

3. A support according to any one of claims 1 or 2, wherein at least some of the multiple small grids have a roughly rhombus shape, which has four sides formed by a pair of filaments among the first multiple filaments extending in the first spiral direction and a pair of filaments among the second multiple filaments extending in the second spiral direction.

4. The stent of any one of claims 1 to 3, wherein the stent further comprises a polymer covering extending along the elongated tubular member.

5. The stent of any one of claims 1 to 4, wherein the one or more rows of cells comprise only broken cells, thereby dividing the elongated tubular member into two or more distinct segments.

6. The bracket according to claim 5, wherein: A first segment of the two or more different segments has a first end having a plurality of cells in a first bottom row; A second segment of the two or more different segments has a second end having a plurality of cells in a second bottom row; and The second section is rotated relative to the first section so that the plurality of small grids in the first last row are nested between the plurality of small grids in the second last row.

7. The stent of any one of claims 5 or 6, wherein a first segment of the two or more different segments has a first weave pattern, and a second segment of the two or more different segments has a second weave pattern different from the first weave pattern.

8. A stent according to any one of claims 5 to 7, wherein the two or more distinct segments are bonded together via fixation elements woven between adjacent segments.

9. A braided stent, comprising: An elongated tubular member expandable from a radially collapsed configuration to a radially expanded configuration, the elongated tubular member comprising: a first segment, the first segment comprising a first plurality of filaments extending in a spiral direction from left to right, and a second plurality of filaments extending in a spiral direction from right to left, the first plurality of filaments and the second plurality of filaments together forming a first plurality of cells arranged in a plurality of rows extending circumferentially around the first segment; and a second segment, the second segment comprising a third plurality of filaments extending in the left-to-right spiral direction and a fourth plurality of filaments extending in the right-to-left spiral direction, the third plurality of filaments and the fourth plurality of filaments together forming a second plurality of cells arranged in a plurality of rows extending circumferentially around the second segment; Wherein the first segment and the second segment are coupled together in a manner to provide increased flexibility to the braided stent.

10. The braided stent of claim 9, wherein the first segment and the second segment are coupled together by making one or more of the third plurality of filaments an extension of one or more of the first plurality of filaments and / or by making one or more of the fourth plurality of filaments an extension of one or more of the second plurality of filaments.

11. The braided stent of any one of claims 9 or 10, wherein the first segment and the second segment are coupled together by a continuous polymer layer extending over at least a portion of the first segment and at least a portion of the second segment.

12. The braided stent according to any one of claims 9 to 11, wherein: The first section has a first end, the first end having a plurality of cells in a first bottom row; The second section has a second end, the second end having a plurality of cells in a second bottom row; and The first section and the second section are coupled together via a securing element woven between the plurality of cells in the first last row and the plurality of cells in the second last row.

13. The braided stent according to any one of claims 9 to 12, further comprising a third segment, the third segment comprising a fifth plurality of filaments extending in a spiral direction from left to right, and a sixth plurality of filaments extending in a spiral direction from right to left, the first plurality of filaments and the second plurality of filaments together forming a first plurality of cells arranged in a plurality of rows extending circumferentially around the first segment; Wherein the second segment and the third segment are coupled together in a manner to provide increased flexibility to the braided stent.

14. A braided stent, comprising: an elongated tubular member expandable from a radially collapsed configuration to a radially expanded configuration, the elongated tubular member comprising a plurality of cells arranged in a plurality of rows extending circumferentially around the elongated tubular member; At least some of the plurality of cells are adapted to increase the flexibility of the support.

15. The braided stent of claim 14, wherein the elongated tubular member comprises a first plurality of filaments extending in a first helical direction and a second plurality of filaments extending in a second helical direction, the first plurality of filaments extending in the first helical direction and the second plurality of filaments extending in the second helical direction overlap to form a plurality of cells arranged in a plurality of rows extending circumferentially around the elongated tubular member; At least some of the first plurality of filaments and at least some of the second plurality of filaments in one or more of the plurality of rows are cut to break at least some of the cells, thereby increasing the flexibility of the stent.